Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients
Authors:
- 2 December 2022
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (2) , 261-270
Abstract
No abstract availableKeywords
Funding Information
- The MIOT project received “no-profit support” from Chiesi Farmaceutici S.p.A.
This publication has 68 references indexed in Scilit:
- Cardiovascular Function and Treatment in β-Thalassemia MajorCirculation, 2013
- The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packagesBritish Journal of Haematology, 2013
- On T2* Magnetic Resonance and Cardiac IronCirculation, 2011
- Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia MajorCirculation, 2009
- Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsAmerican Journal of Hematology, 2009
- Cardiac iron across different transfusion-dependent diseasesBlood Reviews, 2008
- Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia majorHaematologica, 2008
- Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonanceAmerican Heart Journal, 2004
- Iron Overload: Causes and ConsequencesAnnual Review of Nutrition, 1987
- Cardiovascular effects of anemiaAmerican Heart Journal, 1972